Cargando…

Mapping Australian pharmacy school curricula for content related to pharmacogenomics

BACKGROUND: Pharmacogenomics (PGx) is a rapidly growing field which promises to deliver personalized, more effective medications tailored to genetic information. Although the pharmacy profession is expected to lead the translation of pharmacogenomics into widespread clinical implementation, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Venugopal, Maija-Liisa, Yong, Faith R., Krzyzaniak, Natalia, La Caze, Adam, Freeman, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589202/
https://www.ncbi.nlm.nih.gov/pubmed/36299640
http://dx.doi.org/10.1016/j.rcsop.2022.100192
_version_ 1784814249532456960
author Venugopal, Maija-Liisa
Yong, Faith R.
Krzyzaniak, Natalia
La Caze, Adam
Freeman, Christopher
author_facet Venugopal, Maija-Liisa
Yong, Faith R.
Krzyzaniak, Natalia
La Caze, Adam
Freeman, Christopher
author_sort Venugopal, Maija-Liisa
collection PubMed
description BACKGROUND: Pharmacogenomics (PGx) is a rapidly growing field which promises to deliver personalized, more effective medications tailored to genetic information. Although the pharmacy profession is expected to lead the translation of pharmacogenomics into widespread clinical implementation, there is a reported lack of preparedness among its members. Assessing pharmacogenomic-related training in Australian pharmacy program curricula may highlight educational gaps and provide guidance for curricula revision. OBJECTIVE: To examine pharmacogenomic content in Australian tertiary pharmacy program curricula. METHODS: We reviewed the curriculum of 22 Australian registrable pharmacy degrees, including 16 Bachelors of Pharmacy programs (with or without honors) and six Masters of Pharmacy programs, for content related to pharmacogenomics and genetics. This was done by screening the publicly available electronic course profiles on each institution's website and searching for key terms such as “pharmacogenomics,” “pharmacogenetics,” “genes,” and “genetics”. Three mapping activities were completed to assess the breadth and depth of pharmacogenomic training according to; 1. Bloom's taxonomy, 2. Author-assigned domains comprising; Enabling science, Translational science and Clinical implementation, and 3. Pharmacogenomic competencies from the National Human Genome Research Institute (NHGRI). RESULTS: A total of 18 (82%) pharmacy registrable degree programs incorporated pharmacogenomics and/or genetics in their curricula. Four programs (18%) offered standalone PGx courses and 10 (45%) contained integrated PGx content in other science-related courses (i.e. pharmaceutical biology, biochemistry, microbiology etc.). Mapping activities showed that most learning objectives related to the “Understand” level of Bloom's taxonomy (61%), the “Basic Genetic Concepts” domain of NHGRI's competencies (64%) and “Enabling science” (84%). CONCLUSIONS: Most Australian pharmacy registrable degrees have incorporated pharmacogenomic content in their curricula however, the scope of training is limited. Revisions to course curricula should be made to incorporate additional education with a focus on application-based training of clinical pharmacogenomics.
format Online
Article
Text
id pubmed-9589202
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95892022022-10-25 Mapping Australian pharmacy school curricula for content related to pharmacogenomics Venugopal, Maija-Liisa Yong, Faith R. Krzyzaniak, Natalia La Caze, Adam Freeman, Christopher Explor Res Clin Soc Pharm Article BACKGROUND: Pharmacogenomics (PGx) is a rapidly growing field which promises to deliver personalized, more effective medications tailored to genetic information. Although the pharmacy profession is expected to lead the translation of pharmacogenomics into widespread clinical implementation, there is a reported lack of preparedness among its members. Assessing pharmacogenomic-related training in Australian pharmacy program curricula may highlight educational gaps and provide guidance for curricula revision. OBJECTIVE: To examine pharmacogenomic content in Australian tertiary pharmacy program curricula. METHODS: We reviewed the curriculum of 22 Australian registrable pharmacy degrees, including 16 Bachelors of Pharmacy programs (with or without honors) and six Masters of Pharmacy programs, for content related to pharmacogenomics and genetics. This was done by screening the publicly available electronic course profiles on each institution's website and searching for key terms such as “pharmacogenomics,” “pharmacogenetics,” “genes,” and “genetics”. Three mapping activities were completed to assess the breadth and depth of pharmacogenomic training according to; 1. Bloom's taxonomy, 2. Author-assigned domains comprising; Enabling science, Translational science and Clinical implementation, and 3. Pharmacogenomic competencies from the National Human Genome Research Institute (NHGRI). RESULTS: A total of 18 (82%) pharmacy registrable degree programs incorporated pharmacogenomics and/or genetics in their curricula. Four programs (18%) offered standalone PGx courses and 10 (45%) contained integrated PGx content in other science-related courses (i.e. pharmaceutical biology, biochemistry, microbiology etc.). Mapping activities showed that most learning objectives related to the “Understand” level of Bloom's taxonomy (61%), the “Basic Genetic Concepts” domain of NHGRI's competencies (64%) and “Enabling science” (84%). CONCLUSIONS: Most Australian pharmacy registrable degrees have incorporated pharmacogenomic content in their curricula however, the scope of training is limited. Revisions to course curricula should be made to incorporate additional education with a focus on application-based training of clinical pharmacogenomics. Elsevier 2022-10-13 /pmc/articles/PMC9589202/ /pubmed/36299640 http://dx.doi.org/10.1016/j.rcsop.2022.100192 Text en © 2022 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Venugopal, Maija-Liisa
Yong, Faith R.
Krzyzaniak, Natalia
La Caze, Adam
Freeman, Christopher
Mapping Australian pharmacy school curricula for content related to pharmacogenomics
title Mapping Australian pharmacy school curricula for content related to pharmacogenomics
title_full Mapping Australian pharmacy school curricula for content related to pharmacogenomics
title_fullStr Mapping Australian pharmacy school curricula for content related to pharmacogenomics
title_full_unstemmed Mapping Australian pharmacy school curricula for content related to pharmacogenomics
title_short Mapping Australian pharmacy school curricula for content related to pharmacogenomics
title_sort mapping australian pharmacy school curricula for content related to pharmacogenomics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589202/
https://www.ncbi.nlm.nih.gov/pubmed/36299640
http://dx.doi.org/10.1016/j.rcsop.2022.100192
work_keys_str_mv AT venugopalmaijaliisa mappingaustralianpharmacyschoolcurriculaforcontentrelatedtopharmacogenomics
AT yongfaithr mappingaustralianpharmacyschoolcurriculaforcontentrelatedtopharmacogenomics
AT krzyzaniaknatalia mappingaustralianpharmacyschoolcurriculaforcontentrelatedtopharmacogenomics
AT lacazeadam mappingaustralianpharmacyschoolcurriculaforcontentrelatedtopharmacogenomics
AT freemanchristopher mappingaustralianpharmacyschoolcurriculaforcontentrelatedtopharmacogenomics